Noteworthy, the administration of purified CD34+/KDR+ progenitor cells promoted vascular regeneration in ischemic limbs of mice and might therefore provide an interesting tool for therapeutic angiogenesis in ischemic diseases [25]. Here, CD34 is linked to ischemic disease.